GB2089210A - Polymeric diffusion matrix for administration of drugs - Google Patents

Polymeric diffusion matrix for administration of drugs

Info

Publication number
GB2089210A
GB2089210A GB8206466A GB8206466A GB2089210A GB 2089210 A GB2089210 A GB 2089210A GB 8206466 A GB8206466 A GB 8206466A GB 8206466 A GB8206466 A GB 8206466A GB 2089210 A GB2089210 A GB 2089210A
Authority
GB
United Kingdom
Prior art keywords
drug
drugs
diffusion matrix
administration
polymeric diffusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB8206466A
Other versions
GB2089210B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Key Pharmaceuticals Inc
Original Assignee
Key Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/167,009 external-priority patent/US4289749A/en
Priority claimed from US06/167,729 external-priority patent/US4291014A/en
Application filed by Key Pharmaceuticals Inc filed Critical Key Pharmaceuticals Inc
Publication of GB2089210A publication Critical patent/GB2089210A/en
Application granted granted Critical
Publication of GB2089210B publication Critical patent/GB2089210B/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A polymeric diffusion matrix for administering a drug is provided comprising from about 2 to about 60% of a polar plasticizer, e.g., glycerol, from about6 to about 20% of polyvinylalcohol, from about 2 to about 10% of polyvinylpyrrolidone, and a pharmaceutically effective amount of drug, yielding a matrix capable of sustained release of a vasodilator drug dispersed therein, and the balance water, the percentages being by weight. The drugs include terbutaline, ephedrine, clonidine, phenylephrine, estradiol esters, phenylpropanolamine, and chlorpheniramine maleate.
GB8206466A 1980-07-09 1981-06-26 Polymeric diffusion matrix for administration of drugs Expired GB2089210B (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US16700880A 1980-07-09 1980-07-09
US06/167,009 US4289749A (en) 1979-08-14 1980-07-09 Polymeric diffusion matrix containing phenylpropanolamine
US06/167,104 US4292302A (en) 1979-08-14 1980-07-09 Polymeric diffusion matrix containing terbutaline
US06/167,010 US4292301A (en) 1979-08-14 1980-07-09 Polymeric diffusion matrix containing ephedrine
US06/167,101 US4294820A (en) 1979-08-14 1980-07-09 Polymeric diffusion matrix containing phenylephrine
US06/167,106 US4292303A (en) 1979-08-14 1980-07-09 Polymeric diffusion matrix containing clonidine
US06/167,729 US4291014A (en) 1979-01-11 1980-07-11 Polymeric diffusion matrix containing estradiol diacetate
US06/217,400 US4321252A (en) 1979-08-14 1980-12-17 Polymeric diffusion matrix containing ester derivatives of estradiol
PCT/US1981/000893 WO1982000099A1 (en) 1980-07-09 1981-06-26 Polymeric diffusion matrix for administration of drugs

Publications (2)

Publication Number Publication Date
GB2089210A true GB2089210A (en) 1982-06-23
GB2089210B GB2089210B (en) 1984-09-05

Family

ID=41698406

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8206466A Expired GB2089210B (en) 1980-07-09 1981-06-26 Polymeric diffusion matrix for administration of drugs

Country Status (13)

Country Link
JP (1) JPS57500980A (en)
AU (1) AU7415181A (en)
BE (1) BE889549A (en)
CA (1) CA1163559A (en)
CH (1) CH658597A5 (en)
DE (1) DE3152182A1 (en)
FR (1) FR2486397A1 (en)
GB (1) GB2089210B (en)
IT (1) IT1237327B (en)
NL (1) NL8120270A (en)
NO (1) NO153638C (en)
SE (1) SE447448B (en)
WO (1) WO1982000099A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2142234A (en) * 1983-06-29 1985-01-16 Dick P R Pharmaceutical dermal compositions with prolonged and continuous action based on essential fatty acids

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58206751A (en) * 1982-05-26 1983-12-02 日石三菱株式会社 Wound covering material
FR2532546B1 (en) * 1982-09-07 1985-12-27 Biotrol Sa Lab SKIN PROTECTION PASTE
DE3409079A1 (en) * 1984-03-13 1985-09-19 Bayer Ag, 5090 Leverkusen MEDICAL PLASTER
SE457326B (en) * 1986-02-14 1988-12-19 Lejus Medical Ab PROCEDURES FOR PREPARING A QUICK SUBSTANTIAL CANDLES CONTAINING BLA MICROCRISTALLIN CELLULOSA
US4860543A (en) * 1986-08-08 1989-08-29 Helix Technology Corporation Vibration isolation system for a linear reciprocating machine
SU1705319A1 (en) * 1987-10-23 1992-01-15 Всесоюзный Научно-Исследовательский Институт Биотехнологии Polymer diffuse matrix composition for transdermal drug introduction
IT1261305B (en) * 1993-06-22 1996-05-14 Gevipi Ag VIBRATION AND NOISE DAMPING DEVICE, FOR HYDRAULIC SYSTEMS
DE4429667C2 (en) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol TTS with water-binding additives and process for its preparation
US6673363B2 (en) 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
AU2727801A (en) * 1999-12-16 2001-06-25 Dermatrends, Inc. Transdermal administration of phenylpropanolamine
US6602912B2 (en) 2000-06-30 2003-08-05 Dermatrends, Inc. Transdermal administration of phenylpropanolamine
US6719997B2 (en) 2000-06-30 2004-04-13 Dermatrends, Inc. Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2693438A (en) * 1951-02-21 1954-11-02 Norwich Pharma Co Preformed, nonadherent films for application to open lesions
US2804073A (en) * 1953-01-26 1957-08-27 Protective Teatments Inc Fluid surgical dressing
BE638231A (en) * 1962-03-16
US3214338A (en) * 1964-07-31 1965-10-26 Ehrlich Joseph Ronald Medicament releasing film-forming ointments and process of making
SU219116A1 (en) * 1965-11-26 1973-03-20 А. А. Вишневский, Т. Т. Даурова, М. И. Долгина, И. А. Паников, Ф. П. Сидельковска , М. И. Шрайбер FILM FOR PRIMARY PROCESSING OF THE BURN SURFACE
DE1617282A1 (en) * 1965-11-30 1975-02-06 Astra Pharma Prod DEVICE FOR LOCAL ANESTHETIZATION BY LOCAL APPLICATION AND METHOD FOR MANUFACTURING THIS DEVICE
GB1213295A (en) * 1967-04-27 1970-11-25 Boots Pure Drug Co Ltd Improvements in therapeutic compositions for topical application
FR2047874A6 (en) * 1969-06-10 1971-03-19 Nouvel Lucien
US3577516A (en) * 1969-12-02 1971-05-04 Nat Patent Dev Corp Preparation of spray on bandage
DE2012775C3 (en) * 1970-03-18 1973-10-04 V.P. Variopharm Gmbh Herstellung Und Vertrieb Pharmazeutischer, Kosmetischer Und Chemischer Erzeugnisse, 6656 Einoed Ointment foils and process for their manufacture
US3892905A (en) * 1970-08-12 1975-07-01 Du Pont Cold water soluble plastic films
US4210633A (en) * 1978-10-20 1980-07-01 Eli Lilly And Company Flurandrenolide film formulation
IL59063A (en) * 1979-01-11 1983-12-30 Key Pharma Polymeric diffusion matrix for release of pharmaceutical dosage

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2142234A (en) * 1983-06-29 1985-01-16 Dick P R Pharmaceutical dermal compositions with prolonged and continuous action based on essential fatty acids

Also Published As

Publication number Publication date
AU7415181A (en) 1982-02-02
BE889549A (en) 1981-11-03
CH658597A5 (en) 1986-11-28
NO820722L (en) 1982-03-08
CA1163559A (en) 1984-03-13
NO153638C (en) 1986-05-07
JPS57500980A (en) 1982-06-03
NL8120270A (en) 1982-06-01
GB2089210B (en) 1984-09-05
SE8201337L (en) 1982-03-04
IT8219833A0 (en) 1982-02-24
IT1237327B (en) 1993-05-31
WO1982000099A1 (en) 1982-01-21
SE447448B (en) 1986-11-17
DE3152182A1 (en) 1983-02-10
NO153638B (en) 1986-01-20
FR2486397A1 (en) 1982-01-15

Similar Documents

Publication Publication Date Title
GB2089210A (en) Polymeric diffusion matrix for administration of drugs
HUT56290A (en) Plaster of oestrogenic active ingredient content and method for producing same
HU892559D0 (en) Process for the preparation of transdermal pharmaceutical composition suitable for systemic administration, containing deprenyl as active ingredient
KR880001285A (en) Medicinal Western Mechanisms
DE69534538D1 (en) Delayed release of peptides from pharmaceutical compositions
SE8303531D0 (en) PHARMACEUTICAL COMPOSITION
ES446075A1 (en) Sustained-release formulations
EP0177893A3 (en) Sustained release dosage form based on highly plasticized cellulose ether gels
CA2153572A1 (en) Transdermal therapeutic system with galanthamine as active ingredient
NO852966L (en) DELIVERY DEVICE FOR THE FIRST ORDER DELIVERY OF AN ACTIVE INGREDIENT IN A SOLUTION, AND PROCEDURE FOR THE PREPARATION OF THIS.
KR850008279A (en) Method for preparing a transdermal drug
DK0724885T3 (en) Pernasal composition and pernasal preparation containing this
ATE106239T1 (en) CONTROLLED RELEASE PREPARATIONS.
KR880002515A (en) Fast absorbing and acting sullindac or a mixture of sodium sullindak and base
KR860000865A (en) Preparation of Pharmaceutical Formulations
CA2211325A1 (en) Extended release clonidine formulation
ATE69724T1 (en) SELF-ADHESIVE DEVICE FOR TRANSDERMAL DELIVERY OF A DRUG.
KR830002510A (en) Composition consisting of biologically active compound and hydroxyalkyl starch
SE8901003D0 (en) QUICKLY PREPARATION
ATE20311T1 (en) POLYMERIC DIFFUSION MATRIX CONTAINING PROPRANOLOL.
KR920700704A (en) Improved Percutaneous System for Pharmacological Compound Administration Under pH-Controlled Conditions
DK0483320T3 (en) Prolonged-release pharmaceutical compositions for oral administration and methods for their preparation
Junien et al. JO 1784, a new selective ligand for sigma sites: characteristics and functional activity

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee